HKG: 1515

Company Hospital

China Resources Medical Holdings Reports 2024 Revenue of RMB9.86 Billion Amid Net Profit Surge

Fineline Cube Mar 26, 2025

China Resources Medical Holdings Company Ltd (CR Medical, HKG: 1515) has published its 2024 financial...

Company Drug

Shionogi Submits Rolling NDA for Ensitrelvir in US for COVID-19 Prophylaxis

Policy / Regulatory

China’s National Health Commission Outlines Key Tasks for Primary Healthcare Reform in 2025

Company Drug

Pfizer Expands Abrysvo RSV Vaccine Indication to Include Ages 18-59 in EU

Company Drug Legal / IP

AccurEdit’s ARTbase-A1 Base Editor Authorized by USPTO